CAPABILITIES
We are driven by the spirit of constant innovation
in the effort to deliver cutting edge healthcare solutions
In just over a decade, Somerset Pharma has made significant strides in the pharmaceutical industry, emerging as one of the key players in the US market, focusing on development and manufacturing of sterile ophthalmic and injectable products.
Our core area of expertise is sterile manufacturing, and we have successfully produced millions of injectables, bottles, vials, and ampoules through the years, including complex, difficult to manufacture products.
Our manufacturing capabilities now include multiple automated lines dedicated to producing glass ampules, vials, and ophthalmic bottles. Our manufacturing facility in India has been compliant with the standards set by the United States Food and Drug Administration (USFDA) since 2013.
Looking towards the future, we are actively expanding our infrastructure. This includes the construction of two new manufacturing buildings in Bengaluru and one in New Jersey. These additions will enable us to venture into new dosage forms.
Across various entities within our organization, we are deeply involved in research and development efforts aimed at formulating and manufacturing challenging products. Our product range spans various dosage forms that require aseptic processing and terminal sterilization, including wet vials, lyophilized vials, pre-filled syringes, ophthalmic droppers, inhalations, and topicals.
What distinguishes our R&D endeavors is our integration of advanced pharmaceutical technologies into our product development. These technologies encompass colloids and emulsions, micro suspensions and nanosuspensions, microspheres, insoluble salts and drug complexes, in situ gelling systems, and liposomes and lipid complexes.
Our formulation team places great emphasis on pre-formulation, analysis, and scale-up processes. This rigorous approach ensures that our products undergo comprehensive testing and optimization before they reach the market, resulting in high-quality formulations that meet the exacting standards of the pharmaceutical industry.
To support our research and development initiatives, we have made substantial investments in state-of-the-art R&D facilities in New Jersey, United States, and Bengaluru, India. These facilities house sophisticated testing equipment and support the challenging work of formulation development, analytical development, microbiology, and regulatory compliance.
Our strengths and potential in the area of intellectual property are evident through our patents and differentiated submissions over time.
Looking towards the future, we are actively expanding our infrastructure. This includes the construction of two new manufacturing buildings in Bengaluru and one in New Jersey. These additions will enable us to venture into new dosage forms, such as inhalation, topicals, and lyophilization.